TerrAscend (TSNDF) Operating Income (2021 - 2026)
TerrAscend (TSNDF) reported Operating Income of $11.5 million for Q1 2026, down 5.9% year-over-year from $12.2 million in Q1 2025, and up 50.31% quarter-over-quarter from $7.7 million in Q4 2025.
TerrAscend (TSNDF) Operating Income (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Operating Income data on file, last reported at $11.5 million in Q1 2026.
- Operating Income for Q1 2026 came in at $11.5 million, down 5.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.3 million (up 994.28% YoY), and the FY2025 annual result was $42.0 million, up 4616.16% from the prior year.
- Operating Income grew to $11.5 million in Q1 2026 per TSNDF's latest filing, from $7.7 million in the prior quarter.
- Over five years, Operating Income peaked at $284.5 million in Q4 2022 and troughed at -$330.1 million in Q3 2022.
- A 5-year average of -$875764.7 and a median of $7.3 million in 2024 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 3286.17% in 2022 and fell as far as 18550.56% in 2022.
- A 5-year view of Operating Income shows it stood at $284.5 million in 2022, then slumped by 109.11% to -$25.9 million in 2023, then decreased by 1.72% to -$26.4 million in 2024, then surged by 129.08% to $7.7 million in 2025, then surged by 50.31% to $11.5 million in 2026.
- Business Quant data shows TSNDF's Operating Income at $11.5 million in Q1 2026, $7.7 million in Q4 2025, and $11.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -78.32 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 11.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.52 Mn |
| Dec 31, 2025 | 7.67 Mn |
| Sep 30, 2025 | 11.14 Mn |
| Jun 30, 2025 | 10.97 Mn |
| Mar 31, 2025 | 12.24 Mn |
| Dec 31, 2024 | -26.36 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | -25.92 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 284.51 Mn |
| Sep 30, 2022 | -330.12 Mn |
| Jun 30, 2022 | -11.56 Mn |
| Mar 31, 2022 | -7.98 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | 12.24 Mn |